Promoting and facilitating strategies to improve cardiovascular health worldwide

ISCP Featured Sessions 2018

ISCP Webinar: Cardiovascular Risk Management of Diabetes and SGLT2 Inhibitors



Ankylosing spondylitis increases risk for venous thromboembolism

Posted on March 18, 2019

Patients with ankylosing spondylitis demonstrate an increased risk for venous thromboembolism, particularly in the first year after diagnosis, according to findings published... more

Vaping with e-cigarettes raises odds of CV events, depression

Posted on March 18, 2019

NEW ORLEANS — Adults who reported using electronic cigarettes had increased odds of MI, CAD and depression or emotional problems compared with... more

Early discharge, home treatment with rivaroxaban promising in low-risk pulmonary embolism

Posted on March 17, 2019

NEW ORLEANS — Certain patients with acute low-risk pulmonary embolism fared well with early discharge and home treatment with rivaroxaban, according to... more

Intensive statin therapy may benefit patients with CVD, PAD

Posted on March 17, 2019

NEW ORLEANS — Patients with acute coronary disease and dyslipidemia with a history of CVD, peripheral artery disease or both may have... more

ISCP book series

Current Cardiovascular Therapy
Kaski, Juan Carlos.

Series Editor: Juan Carlos Kaski Cardiovascular pharmacotherapy is a fast-moving and complex discipline within cardiology in general. New studies, trials and indications are appearing on a regular basis. This series created with the support of the International Society of Cardiovascular Pharmacotherapy (ISCP) is designed to establish the baseline level of knowledge that a cardiovascular professional needs to know on a day-to-day basis. The information within is designed to allow readers to learn quickly and with certainty the mode of action,...

  • Antiplatelet and Anticoagulation Therapy

    A. Ferro, D.A. Garcia (Eds.)

  • Pharmacological Treatment of Acute Coronary Syndromes

    Avanzas, Pablo; Clemmensen, Peter(Eds.)

  • Atrial Fibrillation Therapy

    Gheorghe-Andrei Dan, Antoni Bayes de Luna, John Camm(Eds.)

board of directors

Providing a leadership and advocacy role amongst members of their national societies.


  • Augusto Gallino


    Affiliations/Memberships University of Zurich Zurich Switzerland Research interests Atherosclerosis ACS CV Imaging Antithrombotic TX (more…) more

  • Hector Ventura


    Affiliations/Memberships Section Head, Cardiomyopathy and Heart Transplant Director, Cardiovascular Disease Training Program (more…) more

  • Pablo Avanzas


    Affiliations/Memberships Consultant in Invasive Cardiology, Hospital Universitario Central de Asturias, Oviedo, Spain Fellow of the European Society (more…) more

  • Thomas Kahan


    Affiliations/Memberships Professor of Medicine Department of Clinical Sciences, Danderyd Hospital Division of Cardiovascular Medicine (more…) more